Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J Smith

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Daniel'S Texas Medical Journal|March 23, 2023
Oxygen in TherapeuticsCharles J Smith
Nuclear Medicine and Biology|August 4, 2009
True radiotracers: Cu-64 targeting vectors based upon bombesin peptideTimothy J Hoffman, Charles J Smith
In Vivo (Athens, Greece)|March 31, 2005
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancerMichael F Giblin, Bhadrasetty Veerendra, Charles J Smith
Iradiology|May 6, 2024
Elevating theranostics: The emergence and promise of radiopharmaceutical cell-targeting heterodimers in human cancersClaudia Chambers, Broc Chitwood, Charles J Smith, et al.
FEMS Microbiology Letters|January 13, 2011
Flavin mononucleotide (FMN)-based fluorescent protein (FbFP) as reporter for gene expression in the anaerobe Bacteroides fragilisLeandro A Lobo, Charles J Smith, Edson R Rocha
Nuclear Medicine and Biology|October 26, 2005
Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypesCharles J Smith, Wynn A Volkert, Timothy J Hoffman
Advances in Experimental Medicine and Biology|October 17, 2018
Peptide-Based Radiopharmaceuticals for Molecular Imaging of Prostate CancerTamila J Stott Reynolds, Charles J Smith, Michael R Lewis
Current Radiopharmaceuticals|March 16, 2015
Lutetium-177 Labeled Bombesin Peptides for Radionuclide TherapyTamila Stott Reynolds, Rajendra P Bandari, Zongrun Jiang, et al.
Molecules (Basel, Switzerland)|May 28, 2025
NOTA and NODAGA Radionuclide Complexing Agents: Versatile Approaches for Advancements in RadiochemistryClaudia G Chambers, Jing Wang, Tamer M Sakr, et al.
ACS Pharmacology & Translational Science|March 19, 2026
Effect of a Negatively Charged Amino Acid Linker on the Tumor-Targeting Properties of [<sup>177</sup>Lu]Lu-Labeled 4‑<i>p</i>‑(Tolyl)butyric Acid-Conjugated Alpha-Melanocyte-Stimulating Hormone PeptidesZheng Qiao, Jingli Xu, Fabio Gallazzi, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Daniel'S Texas Medical Journal|March 23, 2023
Oxygen in TherapeuticsCharles J Smith
Nuclear Medicine and Biology|August 4, 2009
True radiotracers: Cu-64 targeting vectors based upon bombesin peptideTimothy J Hoffman, Charles J Smith
In Vivo (Athens, Greece)|March 31, 2005
Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancerMichael F Giblin, Bhadrasetty Veerendra, Charles J Smith
Iradiology|May 6, 2024
Elevating theranostics: The emergence and promise of radiopharmaceutical cell-targeting heterodimers in human cancersClaudia Chambers, Broc Chitwood, Charles J Smith, et al.
FEMS Microbiology Letters|January 13, 2011
Flavin mononucleotide (FMN)-based fluorescent protein (FbFP) as reporter for gene expression in the anaerobe Bacteroides fragilisLeandro A Lobo, Charles J Smith, Edson R Rocha
Nuclear Medicine and Biology|October 26, 2005
Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypesCharles J Smith, Wynn A Volkert, Timothy J Hoffman
Advances in Experimental Medicine and Biology|October 17, 2018
Peptide-Based Radiopharmaceuticals for Molecular Imaging of Prostate CancerTamila J Stott Reynolds, Charles J Smith, Michael R Lewis
Current Radiopharmaceuticals|March 16, 2015
Lutetium-177 Labeled Bombesin Peptides for Radionuclide TherapyTamila Stott Reynolds, Rajendra P Bandari, Zongrun Jiang, et al.
Molecules (Basel, Switzerland)|May 28, 2025
NOTA and NODAGA Radionuclide Complexing Agents: Versatile Approaches for Advancements in RadiochemistryClaudia G Chambers, Jing Wang, Tamer M Sakr, et al.
ACS Pharmacology & Translational Science|March 19, 2026
Effect of a Negatively Charged Amino Acid Linker on the Tumor-Targeting Properties of [<sup>177</sup>Lu]Lu-Labeled 4‑<i>p</i>‑(Tolyl)butyric Acid-Conjugated Alpha-Melanocyte-Stimulating Hormone PeptidesZheng Qiao, Jingli Xu, Fabio Gallazzi, et al.
Pageof 6